The new technology delivers results in as little as 30 hours and reduces hands-on time by up to 40 percent, according to the company's data.
Background Gastric cancer (GC) ranks among the most prevalent lethal tumours globally. Cancer-associated fibroblasts (CAFs) are pivotal in creating an immunosuppressive tumour microenvironment (TME) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback